API australian pharmaceutical industries limited

Ann: Change in substantial holding, page-3

  1. 132 Posts.
    lightbulb Created with Sketch. 50

    Just an investment firm but they do have WES shares in a lot of their funds. Wondering if they indicated they would vote no with their 8% in addition to WES 19% effectively kiling the SIgma deal as structured as they needed 75% shareholder approval. If so, expect a binding $1.55 offer from WES shortly. I still like the theory WES will eventually acquire both API & Sigma. Fastest way to be able to challenge the market share of EBOS, API needs investment in their Supply Chain which SIgma have already completed which is where a lot of syergy savings would come from. As both Sigma and API have attempted mergers in the last couple of years, its clear that the ACC is a reduced risk as the proposal wouldnt have gone ahead if lawyers didnt believe it was possible to be approved by the ACC. Can only ponder the possibilities.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.